<--- Back to Details
First PageDocument Content
Emotion / Mind / Selective serotonin reuptake inhibitors / Pharmacology / Antidepressant / Management of depression / Anxiety disorder / Major depressive disorder / Sertraline / Psychiatry / Abnormal psychology / Mood disorders
Date: 2005-09-22 15:15:00
Emotion
Mind
Selective serotonin reuptake inhibitors
Pharmacology
Antidepressant
Management of depression
Anxiety disorder
Major depressive disorder
Sertraline
Psychiatry
Abnormal psychology
Mood disorders

The Journal of Mental Health Policy and Economics J. Mental Health Policy Econ. 3, 187–DOI: mhp.95 Antidepressant Treatment for Depression: Total Charges and Therapy Duration

Add to Reading List

Source URL: www.icmpe.org

Download Document from Source Website

File Size: 121,28 KB

Share Document on Facebook

Similar Documents

Medication Guide   Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Medication Guide Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

DocID: 1rlMD - View Document

24. März 2016 FINANCIAL SERVICES OVERVIEW  Complete transparency of

24. März 2016 FINANCIAL SERVICES OVERVIEW Complete transparency of

DocID: 1rk8W - View Document

U.S. SOCCER NATIONAL TEAMS CONCUSSION EVALUATION & MANAGEMENT PROTOCOLS The Return To Play (RTP) decision-making process after concussion is one of the most complicated in sports medicine. Despite ongoing research, the c

U.S. SOCCER NATIONAL TEAMS CONCUSSION EVALUATION & MANAGEMENT PROTOCOLS The Return To Play (RTP) decision-making process after concussion is one of the most complicated in sports medicine. Despite ongoing research, the c

DocID: 1qHSN - View Document

A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders Stephen C. Suffin, M.D. W. Hamlin Emory, M.D. Nicholas Gutierrez, M.D.

A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders Stephen C. Suffin, M.D. W. Hamlin Emory, M.D. Nicholas Gutierrez, M.D.

DocID: 1qAQC - View Document

Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs  Joel M. Kauffman, Ph.D.

Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs Joel M. Kauffman, Ph.D.

DocID: 1pY1S - View Document